to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
Clinical trial NCT07378098 · RECRUITING
Trial details
- NCT number
- NCT07378098
- Sponsor
- JW Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-03
- Primary completion
- 2028-03-31
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.